Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial.

@article{Hoyos2012BodyCA,
  title={Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial.},
  author={Camilla M Hoyos and Brendon J. Yee and Craig L. Phillips and Elizabeth A. Machan and Ronald R Grunstein and Peter Y Liu},
  journal={European journal of endocrinology},
  year={2012},
  volume={167 4},
  pages={531-41}
}
BACKGROUND The combination of male gender, obstructive sleep apnoea (OSA) and obesity magnifies cardiometabolic risk. There has been no systematic study evaluating whether testosterone therapy can improve cardiometabolic health in obese men with OSA by improving body composition, visceral abdominal fat and insulin sensitivity. OBJECTIVE To assess body compositional and cardiometabolic effects of testosterone treatment in obese men with severe OSA. DESIGN An 18-week randomised, double-blind… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 42 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 75 references

Similar Papers

Loading similar papers…